These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19481698

  • 1. Low molecular weight chitosan in DNA vaccine delivery via mucosa.
    Yang X, Yuan X, Cai D, Wang S, Zong L.
    Int J Pharm; 2009 Jun 22; 375(1-2):123-32. PubMed ID: 19481698
    [Abstract] [Full Text] [Related]

  • 2. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
    Gao S, Chen J, Dong L, Ding Z, Yang YH, Zhang J.
    Eur J Pharm Biopharm; 2005 Aug 22; 60(3):327-34. PubMed ID: 15894474
    [Abstract] [Full Text] [Related]

  • 3. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 4. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine.
    Zhou X, Zhang X, Yu X, Zha X, Fu Q, Liu B, Wang X, Chen Y, Chen Y, Shan Y, Jin Y, Wu Y, Liu J, Kong W, Shen J.
    Biomaterials; 2008 Jan 16; 29(1):111-7. PubMed ID: 17905427
    [Abstract] [Full Text] [Related]

  • 5. Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.
    Yuan X, Yang X, Cai D, Mao D, Wu J, Zong L, Liu J.
    Vaccine; 2008 Jul 04; 26(29-30):3727-34. PubMed ID: 18524427
    [Abstract] [Full Text] [Related]

  • 6. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
    Csaba N, Köping-Höggård M, Alonso MJ.
    Int J Pharm; 2009 Dec 01; 382(1-2):205-14. PubMed ID: 19660537
    [Abstract] [Full Text] [Related]

  • 7. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers.
    Köping-Höggård M, Vårum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, Artursson P.
    Gene Ther; 2004 Oct 01; 11(19):1441-52. PubMed ID: 15269712
    [Abstract] [Full Text] [Related]

  • 8. Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo.
    Dong L, Gao S, Diao H, Chen J, Zhang J.
    J Biomed Mater Res A; 2008 Mar 01; 84(3):777-84. PubMed ID: 17635017
    [Abstract] [Full Text] [Related]

  • 9. Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking.
    Strand SP, Lelu S, Reitan NK, de Lange Davies C, Artursson P, Vårum KM.
    Biomaterials; 2010 Feb 01; 31(5):975-87. PubMed ID: 19857892
    [Abstract] [Full Text] [Related]

  • 10. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.
    Germershaus O, Mao S, Sitterberg J, Bakowsky U, Kissel T.
    J Control Release; 2008 Jan 22; 125(2):145-54. PubMed ID: 18023906
    [Abstract] [Full Text] [Related]

  • 11. Hydrophobically modified low molecular weight chitosans as efficient and nontoxic gene delivery vectors.
    Zhang X, Ercelen S, Duportail G, Schaub E, Tikhonov V, Slita A, Zarubaev V, Babak V, Mély Y.
    J Gene Med; 2008 May 22; 10(5):527-39. PubMed ID: 18265422
    [Abstract] [Full Text] [Related]

  • 12. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S, Zhao Y, Wu F, Zhang X, Lü W, Zhang H, Zhang Q.
    Int J Pharm; 2004 Aug 20; 281(1-2):11-23. PubMed ID: 15288339
    [Abstract] [Full Text] [Related]

  • 13. Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes.
    Strand SP, Danielsen S, Christensen BE, Vårum KM.
    Biomacromolecules; 2005 Aug 20; 6(6):3357-66. PubMed ID: 16283766
    [Abstract] [Full Text] [Related]

  • 14. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO, Somavarapu S, Atuah KN, Bramwell VW.
    Adv Drug Deliv Rev; 2005 Jan 10; 57(3):411-30. PubMed ID: 15560949
    [Abstract] [Full Text] [Related]

  • 15. Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan.
    Yuan ZX, Zhang ZR, Zhu D, Sun X, Gong T, Liu J, Luan CT.
    Mol Pharm; 2009 Jan 10; 6(1):305-14. PubMed ID: 19035784
    [Abstract] [Full Text] [Related]

  • 16. Receptor-mediated gene delivery using chemically modified chitosan.
    Kim TH, Jiang HL, Nah JW, Cho MH, Akaike T, Cho CS.
    Biomed Mater; 2007 Sep 10; 2(3):S95-100. PubMed ID: 18458467
    [Abstract] [Full Text] [Related]

  • 17. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
    Jiang HL, Kang ML, Quan JS, Kang SG, Akaike T, Yoo HS, Cho CS.
    Biomaterials; 2008 Apr 10; 29(12):1931-9. PubMed ID: 18221992
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan.
    Lee E, Lee J, Jon S.
    Bioconjug Chem; 2010 Oct 20; 21(10):1720-3. PubMed ID: 20849099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.